This study will be conducted in an observational multiple-cohort design aimed at acquiring clinical, treatment, health status, and economic data. Patients with Parkinson's disease (PD) will be enrolled.
All patients attending the physician and fulfilling the eligibility criteria are included.
Study Type
OBSERVATIONAL
Enrollment
2,195
Change From Baseline in Unified Parkinson's Disease Rating Scale (UPDRS) Part III at Visit 7 (Month 33)
The Unified Parkinson's disease rating scale (UPDRS) Part III (Motor Examination) contains 31 questions. Each question ranges from 0 (best possible outcome) to 4 (worst outcome). The total score ranges from 0 (best possible outcome) to 124 (worst outcome).
Time frame: From Baseline to Visit 7 (Month 33)
Change From Baseline in Unified Parkinson's Disease Rating Scale (UPDRS) Question 32 of Part IV at Visit 7 (Month 33)
The Unified Parkinson's disease rating scale (UPDRS) question 32 of part IV asks. "What Proportion of the waking day are dyskinesias present?" Answers range from 0 (None) to 4 (76-100 % of the day).
Time frame: From Baseline to Visit 7 (Month 33)
Change From Baseline in Unified Parkinson's Disease Rating Scale (UPDRS) Question 33 of Part IV at Visit 7 (Month 33)
The Unified Parkinson's disease rating scale (UPDRS) Part IV question 33 asks for complications of therapy in the past week, through the question "How disabling are the dyskinesias ? " Answers range from 0 (Not disabling) to 4 (Completely disabling).
Time frame: From Baseline to Visit 7 (Month 33)
Change From Baseline in Unified Parkinson's Disease Rating Scale (UPDRS) Question 39 of Part IV at Visit 7 (Month 33)
The Unified Parkinson's disease rating scale (UPDRS) Part IV question 39 asks "What proportion of the waking day is the patient "off", on average?" Answers range from 0 (None) to 4 (76-100 % of the day).
Time frame: 33 months
Change From Baseline in Nocturnal Dystonia Cramp Score (NADCS) at Visit 7 (Month 33)
The NADCS assesses sleep-related motor complaints including nocturnal akinesia, dystonia and painful cramps by an ordinal severity scale. The NADCS total score ranges from 0 (normal) to 4 (maximum severity). NADCS value was missing for one subject at Visit 7.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
813
Chomutov, Czechia
808
Hradec Králové, Czechia
822
Hradec Králové, Czechia
811
Litomyšl, Czechia
803
Ostrava-Poruba, Czechia
809
Pardubice, Czechia
817
Písek, Czechia
814
Plzen-Lochotin, Czechia
804
Prague, Czechia
805
Prague, Czechia
...and 201 more locations
Time frame: 33 months
Hoehn & Yahr Stage at Visit 7 (Month 33)
The Hoehn and Yahr staging of Parkinson's disease in the "on" stage, if applicable, had to be completed by the physician. Possible staging: * 0 No signs of disease * 1 Unilateral disease * 2 Bilateral disease without impairment of balance * 3 Mild to moderate bilateral disease, some postural instability, physically dependent * 4 Severe disability, still able to walk or stand unassisted * 5 Wheelchair bound or bedridden unless aided
Time frame: 33 months
Reported Adverse Events of Cardiac Valve Fibrosis During the Study (up to 33 Months)
The analysis was performed for the non-disjunctive classification into patients at risk to develop an Adverse Event associated with Rotigotine and patients at risk to develop an Adverse Event not associated with Rotigotine.
Time frame: 33 months